Metachromatic leukodystrophy refers to a group of genetic neurologic diseases caused by deficiencies of the enzyme arylsulfatase A and the resulting accumulation of sulfatides in white matter. Bone marrow transplantation has been advocated as a treatment in an attempt to correct the enzyme deficiency. Such a transplant was performed in 1991 in a 16-year-old girl with a form of late juvenile metachromatic leukodystrophy caused by a homozygous P426L mutation in the arylsulfatase A gene. Engraftment was prompt and resulted in constant enzymatic normalization of circulating lymphocytes. The elevated urinary excretion of sulfatides remained unaffected. Clinical findings up until transplantation consisted of gait disturbances, impairment of cognitive functioning, and deterioration in school performance over several years. During a 6-year follow-up period, the patient's condition was subject to major fluctuations but, on the whole, findings showed slow neurologic and neurophysiologic deterioration. The clinical course observed after bone marrow transplantation probably more or less reflects the natural course expected in this form of late-onset metachromatic leukodystrophy. (J Child Neurol 1999; 14:222-228).
Get full access to this article
View all access options for this article.
References
1.
Neufeld EF: The uptake of enzymes into lysosomes: An overview. Birth Defects1980;16:77-84.
2.
Hoogerbrugge PM, Brouwer OF, Bordigoni P., et al: Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation . Lancet1995 ;345: 1398-1402.
3.
Krivit W., Lockman LA, Watkins PA, et al: The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. J Inher Metab Dis1995 ; 18:398-412.
4.
Hoogerbrugge PM, Suzuki K. Suzuki K, et al: Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation . Science1988;239:1035-1038.
5.
Birkenmeier EH , Barker JE, Vogler CA, et al: Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood1991;78:3081-3092.
6.
Bou-Gharios G. , Adams G., Pace P., et al: Correction of a lysosomal deficiency by contact-mediated enzyme transfer after bone marrow transplantation. Transplantation1993;56:991-996.
7.
Walkley SU, Thrall MA, Dobrenis K., et al: Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease. Proc Natl Acad Sci USA1994;91:2970-2974.
8.
Krivit W., Sung JH, Shapiro EG, Lockman LA: Microglia: The effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases. Cell Transplant1995;4:385-392.
9.
Walkley SU, Dobrenis K.: Bone marrow transplantation for lysosomal diseases, comment. Lancet1995;345:1382-1383.
10.
Krivit W., Lipton ME, Lockman LA, et al: Prevention of deterioration in metachromatic leukodystrophy by bone marrow transplantation. Am J Med Sci1987;294:80-85.
11.
Krivit W., Shapiro E., Kennedy W., et al: Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation, comments. N Engl J Med1990;322:28-32.
12.
Dhuna A., Toro C., Torres F., et al: Longitudinal neurophysiologic studies in a patient with metachromatic leukodystrophy following bone marrow transplantation. Arch Neurol1992;49:1088-1092.
13.
Shapiro EG, Lockman LA, Balthazor M., Krivit W.: Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis1995;18:413-429.
14.
Pridjian G. , Humbert J., Willis J., Shapiro E.: Presymptomatic late-infantile metachromatic leukodystrophy treated with bone marrow transplantation . J Pediatr1994;125:755-758.
15.
Malm G., Ringden O., Winiarski J., et al: Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation. Bone Marrow Transplant1996;17: 1003-1008.
16.
Bayever E., Ladisch S., Philippart M., et al: Bone-marrow transplantation for metachromatic leucodystrophy . Lancet1985;2: 471-473.
17.
Imaizumi M. , Gushi K., Kurobane I., et al: Long-term effects of bone marrow transplantation for inborn errors of metabolism: A study of four patients with lysosomal storage diseases. Acta Paediatr Jpn1994;36:30-36.
18.
Stillman AE , Krivit W., Shapiro E., et al: Serial MR after bone marrow transplantation in two patients with metachromatic leukodystrophy . Am J Neuroradiol1994;15:1929-1932.
19.
Guffon N., Souillet G., Maire I., et al: Juvenile metachromatic leukodystrophy: Neurological outcome two years after bone marrow transplantation. J Inherit Metab Dis1995;18:159-161.
20.
Navarro C., Fernandez JM, Dominguez C., et al: Late juvenile metachromatic leukodystrophy treated with bone marrow transplantation; a 4-year follow-up study. Neurology1996;46:254-256.
21.
von Figura K., Steckel F., Hasilik A:Juvenile and adult metachromatic leukodystrophy: Partial restoration of arylsulfatase A activity by inhibitors of thiol proteinases . Proc Natl Acad Sci USA1983;80:6066-6070.
22.
Kappler J., Leinekugel P., Conzelmann E., et al: Genotype-phenotype relationship in various degrees of arylsulfatase A deficiency. Hum Genet1991;86:463-470.
23.
Polten A., Fluharty AL, Fluharty CB, et al: Molecular basis of different forms of metachromatic leukodystrophy, comment. N Engl J Med1991;324:18-22.
24.
Demaerel P. , Faubert C., Wilms G., et al: MR findings in leukodystrophy. Neuroradiology1991;33:368-371.
25.
Wechsler D.: Wechsler Intelligence Scale for Children - Revised. San Antonio, TX: Psychological Corp, 1973.
26.
Hyde TM, Ziegler JC, Weinberger DR: Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis, comment. Arch Neurol1992;49:401-406.
27.
Kolodny EH, Fluharty AL: Metachromatic leukodystrophy and multiple sulfatase deficiency: Sulfatide lipidosis, in Scriver CR, Beaudet AL, Sly WS, et al (eds): The Metabolic and Molecular Basis of Inherited Disease , 7th ed, vol 2. New York, McGraw-Hill, 1995, pp 2693-2739.
28.
Kreysing J. , von Figura K., Gieselmann V:Structure of the human arylsulphatase A gene . Eur J Biochem1990;191:627-631.
29.
Gieselmann V., Zlotogora J., Harris A., et al: Molecular genetics of metachromatic leukodystrophy. Hum Mutat1994;4:233-242.
30.
Barth ML, Fensom A., Harris A.: Identification of seven novel mutations associated with metachromatic leukodystrophy . Hum Mutat1995;6:170-176.
31.
Leinekugel P., Michel S., Conzelmann E., Sandhoff K.: Quantitative correlation between the residual activity of ß-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet1992;88:513-523.
32.
Penzien JM, Kappler J., Herschkowitz N., et al: Compound heterozygosity for metachromatic leukodystrophy and arylsulfatase A pseudodeficiency alleles is not associated with progressive neurological disease. Am J Hum Genet1993;52:557-564.
33.
Shapiro EG, Lockman LA, Knopman D., Krivit W.: Characteristics of the dementia in late-onset metachromatic leukodystrophy . Neurology1994;44:662-665.
34.
Kidd D., Nelson J., Jones F., et al: Long-term stabilization after bone marrow transplantation in juvenile metachromatic leukodystrophy. Arch Neurol1998;55:98-99.
35.
Peters C., Waye JS, Vellodi A., et al: Hematopoietic stem cell transplantation for metachromatic leukodystrophy prior to onset of clinical signs and symptoms, in Ringden O, Hobbs JR, Stewart CG (eds): Correction of Genetic Diseases by Transplantation 1997. London, COGENT, 1997, pp 34-48.
